No., subject, TM-score, RMSD, Sequence Identity, Subject length, Aligned length, Description
1, d1c1bA2, 1.0000, 0.00, 1.000, 422, 422, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GCA- 186
2, d1rthA2, 0.9928, 0.64, 1.000, 428, 422, HIGH RESOLUTION STRUCTURES OF HIV-1 RT FROM FOUR RT- INHIBITOR COMPLEXES
3, d3dleA1, 0.9927, 0.64, 1.000, 425, 422, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GF128590.
4, d1jlaA2, 0.9905, 0.51, 0.998, 422, 420, CRYSTAL STRUCTURE OF Y181C MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH TNK-651
5, d1rtiA2, 0.9904, 0.86, 1.000, 428, 422, HIGH RESOLUTION STRUCTURES OF HIV-1 RT FROM FOUR RT- INHIBITOR COMPLEXES
6, d1rt2A2, 0.9898, 0.76, 1.000, 428, 422, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH TNK-651
7, d1s1vA2, 0.9895, 0.68, 0.995, 423, 421, CRYSTAL STRUCTURE OF L100I MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH TNK-651
8, d1rt1A2, 0.9895, 0.77, 1.000, 428, 422, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH MKC-442
9, d1fkpA2, 0.9882, 0.84, 0.998, 428, 422, CRYSTAL STRUCTURE OF NNRTI RESISTANT K103N MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH NEVIRAPINE
10, d1c1cA2, 0.9875, 0.84, 1.000, 426, 422, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH TNK- 6123
11, d1rt6A2, 0.9844, 0.94, 1.000, 428, 422, HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH UC38
12, d1klmA2, 0.9829, 0.91, 1.000, 427, 421, HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH BHAP U-90152
13, d1jlfA2, 0.9826, 0.99, 0.998, 428, 422, CRYSTAL STRUCTURE OF Y188C MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH NEVIRAPINE
14, d3dolA1, 0.9810, 1.07, 0.995, 425, 422, CRYSTAL STRUCTURE OF L100I MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GW695634.
15, d1c0uA2, 0.9799, 1.07, 1.000, 428, 422, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH BM+50.0934
16, d1rt7A2, 0.9796, 0.87, 1.000, 425, 419, HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH UC84
17, d1jlbA2, 0.9794, 0.83, 0.990, 424, 418, CRYSTAL STRUCTURE OF Y181C MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH NEVIRAPINE
18, d2opsA2, 0.9792, 0.92, 0.998, 421, 419, CRYSTAL STRUCTURE OF Y188C MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GW420867X.
19, d3dmjA1, 0.9786, 0.91, 0.995, 421, 419, CRYSTAL STRUCTURE OF HIV-1 V106A AND Y181C MUTANT REVERSE TRANSCRIPTASE IN COMPLEX WITH GW564511.
20, d3dlgA1, 0.9781, 0.98, 1.000, 421, 419, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GW564511.
21, d1jlqA2, 0.9781, 1.14, 0.993, 422, 420, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH 739W94
22, d3dokA1, 0.9779, 1.15, 0.995, 425, 422, CRYSTAL STRUCTURE OF K103N MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GW678248.
23, d1rt4A2, 0.9774, 0.81, 0.998, 423, 417, HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH UC781
24, d1rtjA2, 0.9768, 1.16, 1.000, 428, 422, MECHANISM OF INHIBITION OF HIV-1 REVERSE TRANSCRIPTASE BY NON-NUCLEOSIDE INHIBITORS
25, d1s1tA2, 0.9765, 0.82, 0.998, 419, 417, CRYSTAL STRUCTURE OF L100I MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH UC-781
26, d1dttA2, 0.9765, 1.07, 0.993, 426, 420, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH PETT- 2 (PETT130A94)
27, d1rt5A2, 0.9764, 0.85, 0.998, 423, 417, HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH UC10
28, d3dm2A1, 0.9757, 0.99, 0.998, 421, 419, CRYSTAL STRUCTURE OF HIV-1 K103N MUTANT REVERSE TRANSCRIPTASE IN COMPLEX WITH GW564511.
29, d1jlgA2, 0.9746, 0.93, 1.000, 419, 417, CRYSTAL STRUCTURE OF Y188C MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH UC-781
30, d2oprA1, 0.9683, 1.10, 0.998, 419, 417, CRYSTAL STRUCTURE OF K101E MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GW420867X.
31, d1tkxA2, 0.9683, 0.86, 1.000, 418, 414, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GW490745
32, d1fkoA2, 0.9625, 1.52, 0.993, 428, 422, CRYSTAL STRUCTURE OF NNRTI RESISTANT K103N MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH DMP-266(EFAVIRENZ)
33, d1jkhA2, 0.9608, 1.40, 0.986, 425, 419, CRYSTAL STRUCTURE OF Y181C MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH DMP-266(EFAVIRENZ)
34, d1s1xA2, 0.9593, 1.38, 0.986, 420, 418, CRYSTAL STRUCTURE OF V108I MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH NEVIRAPINE
35, d1jlcA2, 0.9580, 1.21, 0.998, 416, 414, CRYSTAL STRUCTURE OF Y181C MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH PETT-2
36, d1jleA2, 0.9421, 1.10, 1.000, 408, 406, CRYSTAL STRUCTURE OF Y188C MUTANT HIV-1 REVERSE TRANSCRIPTASE
37, d3i0rA1, 0.9377, 2.05, 0.981, 429, 422, CRYSTAL STRUCTURE OF HIV REVERSE TRANSCRIPTASE IN COMPLEX WITH INHIBITOR 3
38, d2rkiA2, 0.9376, 2.09, 0.976, 429, 422, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH A TRIAZOLE DERIVED NNRTI
39, d1lwfA2, 0.9375, 1.71, 0.993, 417, 415, CRYSTAL STRUCTURE OF A MUTANT HIV-1 REVERSE TRANSCRIPTASE (RTMQ+M184V: M41L/D67N/K70R/M184V/T215Y) IN COMPLEX WITH NEVIRAPINE
40, d3lanA1, 0.9373, 2.09, 0.976, 429, 422, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH N1-BUTYL PYRIMIDINEDIONE NON-NUCLEOSIDE INHIBITOR
41, d2b6aA1, 0.9369, 2.21, 0.979, 429, 422, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH THR-50
42, d1ikwA2, 0.9368, 2.06, 0.974, 429, 422, WILD TYPE HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH EFAVIRENZ
43, d3i0sA1, 0.9360, 2.10, 0.976, 429, 422, CRYSTAL STRUCTURE OF HIV REVERSE TRANSCRIPTASE IN COMPLEX WITH INHIBITOR 7
44, d3lamA1, 0.9359, 2.11, 0.981, 429, 422, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH N1-PROPYL PYRIMIDINEDIONE NON-NUCLEOSIDE INHIBITOR
45, d3lalA1, 0.9359, 2.12, 0.976, 429, 422, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH N1-ETHYL PYRIMIDINEDIONE NON-NUCLEOSIDE INHIBITOR
46, d1ikyA2, 0.9355, 2.11, 0.972, 429, 422, HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH THE INHIBITOR MSC194
47, d4i7fA1, 0.9345, 2.16, 0.976, 429, 422, HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH A PHOSPHONATE ANALOG OF NEVIRAPINE
48, d3c6tA2, 0.9343, 2.13, 0.976, 429, 422, CRYSTAL STRUCTURE OF HIV REVERSE TRANSCRIPTASE IN COMPLEX WITH INHIBITOR 14
49, d3lakA1, 0.9342, 2.15, 0.976, 429, 422, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH N1-HETEROCYCLE PYRIMIDINEDIONE NON-NUCLEOSIDE INHIBITOR
50, d3ffiA1, 0.9342, 2.17, 0.969, 425, 422, HIV-1 RT WITH PYRIDONE NON-NUCLEOSIDE INHIBITOR
51, d2rf2A2, 0.9340, 2.13, 0.974, 426, 422, HIV REVERSE TRANSCRIPTASE IN COMPLEX WITH INHIBITOR 7E (NNRTI)
52, d5fdlA1, 0.9336, 2.16, 0.964, 425, 422, CRYSTAL STRUCTURE OF K103N/Y181C MUTANT HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH IDX899
53, d2wonA1, 0.9336, 2.16, 0.976, 429, 422, CRYSTAL STRUCTURE OF UK-453061 BOUND TO HIV-1 REVERSE TRANSCRIPTASE (WILD-TYPE).
54, d1ikxA2, 0.9336, 2.13, 0.972, 429, 422, K103N MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH THE INHIBITOR PNU142721
55, d1ikvA2, 0.9335, 2.08, 0.974, 428, 421, K103N MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH EFIVARENZ
56, d1hniA2, 0.9334, 2.25, 0.974, 429, 422, STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN A COMPLEX WITH THE NONNUCLEOSIDE INHIBITOR ALPHA-APA R 95845 AT 2.8 ANGSTROMS RESOLUTION
57, d3drsA2, 0.9333, 2.16, 0.974, 429, 422, HIV REVERSE TRANSCRIPTASE K103N MUTANT IN COMPLEX WITH INHIBITOR R8D
58, d4kkoA1, 0.9332, 2.35, 0.969, 429, 422, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH 4- ((4-METHOXY-6-(2-MORPHOLINOETHOXY)-135-TRIAZIN-2-YL)AMINO)-2-((3- METHYLBUT-2-EN-1-YL)OXY)BENZONITRILE (JLJ513) A NON-NUCLEOSIDE INHIBITOR
59, d3lp1A1, 0.9331, 2.17, 0.972, 425, 422, HIV-1 REVERSE TRANSCRIPTASE WITH INHIBITOR
60, d3di6A2, 0.9331, 2.18, 0.974, 425, 422, HIV-1 RT WITH PYRIDAZINONE NON-NUCLEOSIDE INHIBITOR
61, d2yngA1, 0.9329, 2.18, 0.976, 429, 422, HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH INHIBITOR GSK560
62, d3drrA2, 0.9326, 2.17, 0.974, 429, 422, HIV REVERSE TRANSCRIPTASE Y181C MUTANT IN COMPLEX WITH INHIBITOR R8E
63, d4kv8A1, 0.9325, 2.19, 0.976, 429, 422, CRYSTAL STRUCTURE OF HIV RT IN COMPLEX WITH BILR0355BS
64, d3qipA1, 0.9324, 2.13, 0.974, 427, 422, STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH AN RNASE H INHIBITOR AND NEVIRAPINE
65, d2ynhA1, 0.9324, 2.19, 0.976, 429, 422, HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH INHIBITOR GSK500
66, d3dyaA1, 0.9321, 2.20, 0.969, 425, 422, HIV-1 RT WITH NON-NUCLEOSIDE INHIBITOR ANNULATED PYRAZOLE 1
67, d2yniA1, 0.9320, 2.20, 0.976, 429, 422, HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH INHIBITOR GSK952
68, d3e01A1, 0.9319, 2.20, 0.974, 425, 422, HIV-RT WITH NON-NUCLEOSIDE INHIBITOR ANNULATED PYRAZOLE 2
69, d3drpA2, 0.9317, 2.19, 0.976, 429, 422, HIV REVERSE TRANSCRIPTASE IN COMPLEX WITH INHIBITOR R8E
70, d3megA1, 0.9313, 2.17, 0.979, 429, 422, HIV-1 K103N REVERSE TRANSCRIPTASE IN COMPLEX WITH TMC278
71, d4ncgA1, 0.9312, 2.21, 0.976, 426, 422, DISCOVERY OF DORAVIRINE AN ORALLY BIOAVAILABLE NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR POTENT AGAINST A WIDE RANGE OF RESISTANT MUTANT HIV VIRUSES
72, d3c6uA2, 0.9309, 2.20, 0.976, 429, 422, CRYSTAL STRUCTURE OF HIV REVERSE TRANSCRIPTASE IN COMPLEX WITH INHIBITOR 22
73, d3lp0A1, 0.9308, 2.21, 0.972, 426, 422, HIV-1 REVERSE TRANSCRIPTASE WITH INHIBITOR
74, d3t1aA1, 0.9305, 2.23, 0.972, 425, 422, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (K103N MUTANT) IN COMPLEX WITH INHIBITOR M05
75, d4ko0A1, 0.9304, 2.37, 0.969, 428, 421, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH AN ANILINYLPYRIMIDINE DERIVATIVE (JLJ-135)
76, d4ig3A1, 0.9302, 2.39, 0.969, 429, 422, HIV-1 REVERSE TRANSCRIPTASE WITH BOUND FRAGMENT NEAR KNUCKLES SITE
77, d2ynfA1, 0.9299, 2.22, 0.976, 426, 422, HIV-1 REVERSE TRANSCRIPTASE Y188L MUTANT IN COMPLEX WITH INHIBITOR GSK560
78, d4ig0A1, 0.9298, 2.40, 0.993, 429, 422, HIV-1 REVERSE TRANSCRIPTASE WITH BOUND FRAGMENT AT THE 507 SITE
79, d4idkA1, 0.9296, 2.41, 0.969, 429, 422, HIV-1 REVERSE TRANSCRIPTASE WITH BOUND FRAGMENT AT THE 428 SITE
80, d4h4oA1, 0.9296, 2.33, 0.972, 429, 422, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH (E)-3-(3-(2-(2-(24-DIOXO-34-DIHYDROPYRIMIDIN-1(2H)-YL)ETHOXY)- 4- FLUOROPHENOXY)-5-FLUOROPHENYL)ACRYLONITRILE (JLJ506) A NON- NUCLEOSIDE INHIBITOR
81, d3is9A1, 0.9291, 2.43, 0.986, 429, 422, CRYSTAL STRUCTURE OF THE HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH THE ALKENYLDIARYLMETHANE (ADAM) NON-NUCLEOSIDE RT INHIBITOR DIMETHYL 33 -(6-METHOXY-6-OXOHEX-1-ENE-11- DIYL)BIS(5-CYANO-6-METHOXYBENZOATE).
82, d4ifyA1, 0.9289, 2.42, 0.969, 429, 422, HIV-1 REVERSE TRANSCRIPTASE WITH BOUND FRAGMENT AT THE KNUCKLES SITE
83, d2ykmA1, 0.9289, 2.23, 0.972, 429, 422, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH A DIFLUOROMETHYLBENZOXAZOLE (DFMB) PYRIMIDINE THIOETHER DERIVATIVE A NON-NUCLEOSIDE RT INHIBITOR (NNRTI)
84, d2jleA1, 0.9289, 2.25, 0.974, 429, 422, NOVEL INDAZOLE NNRTIS CREATED USING MOLECULAR TEMPLATE HYBRIDIZATION BASED ON CRYSTALLOGRAPHIC OVERLAYS
85, d3meeA1, 0.9288, 2.20, 0.981, 429, 422, HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH TMC278
86, d5vqtA1, 0.9287, 2.29, 0.995, 422, 419, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH 2- CHLORO-N-(6-CYANO-3-(2-(2-(24-DIOXO-34-DIHYDROPYRIMIDIN-1(2H)-YL) ETHOXY)PHENOXY)-4-METHYLNAPHTHALEN-1-YL)-N-METHYLACETAMIDE (JLJ686) A NON-NUCLEOSIDE INHIBITOR
87, d4ifvA1, 0.9287, 2.42, 0.969, 429, 422, DETECTING ALLOSTERIC SITES OF HIV-1 REVERSE TRANSCRIPTASE BY X-RAY CRYSTALLOGRAPHIC FRAGMENT SCREENING
88, d5vqyA1, 0.9286, 2.30, 0.971, 422, 419, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (K103N Y181C) VARIANT IN COMPLEX WITH N-(6-CYANO-3-(2-(2-(24-DIOXO-34- DIHYDROPYRIMIDIN-1(2H)-YL)ETHOXY)PHENOXY)-4-METHYLNAPHTHALEN-1-YL)-N- METHYLACRYLAMIDE (JLJ684) A NON-NUCLEOSIDE INHIBITOR
89, d5vqwA1, 0.9286, 2.30, 0.990, 422, 419, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (Y181C) VARIANT IN COMPLEX WITH N-(6-CYANO-3-(2-(2-(24-DIOXO-34-DIHYDROPYRIMIDIN- 1(2H)-YL)ETHOXY)PHENOXY)-4-METHYLNAPHTHALEN-1-YL)ACRYLAMIDE (JLJ685) A NON-NUCLEOSIDE INHIBITOR
90, d5vqrA1, 0.9285, 2.29, 0.995, 422, 419, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH N-(6- CYANO-3-(2-(2-(24-DIOXO-34-DIHYDROPYRIMIDIN-1(2H)-YL)ETHOXY) PHENOXY)-4-METHYLNAPHTHALEN-1-YL)-N-METHYLACRYLAMIDE (JLJ684) A NON- NUCLEOSIDE INHIBITOR
91, d5c25A1, 0.9285, 2.42, 0.969, 431, 422, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH 6- ((4-((4-CYANOPHENYL)AMINO)-135-TRIAZIN-2-YL)AMINO)-57-DIMETHYL-2- NAPHTHONITRILE (JLJ639) A NON-NUCLEOSIDE INHIBITOR
92, d2ze2A1, 0.9285, 2.34, 0.969, 429, 421, CRYSTAL STRUCTURE OF L100I/K103N MUTANT HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH TMC278 (RILPIVIRINE) A NON-NUCLEOSIDE RT INHIBITOR
93, d5vqqA1, 0.9284, 2.30, 0.995, 422, 419, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH N-(6- CYANO-3-(2-(2-(24-DIOXO-34-DIHYDROPYRIMIDIN-1(2H)-YL)ETHOXY) PHENOXY)-4-METHYLNAPHTHALEN-1-YL)-2-FLUORO-N-METHYLACETAMIDE (JLJ683) A NON-NUCLEOSIDE INHIBITOR
94, d3t19A1, 0.9284, 2.27, 0.974, 425, 422, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (WILD TYPE) IN COMPLEX WITH INHIBITOR M05
95, d1hnvA2, 0.9284, 2.31, 0.974, 429, 422, STRUCTURE OF HIV-1 RT(SLASH)TIBO R 86183 COMPLEX REVEALS SIMILARITY IN THE BINDING OF DIVERSE NONNUCLEOSIDE INHIBITORS
96, d5vqzA1, 0.9283, 2.30, 0.971, 422, 419, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (K103N Y181C) VARIANT IN COMPLEX WITH 2-CHLORO-N-(6-CYANO-3-(2-(2-(24-DIOXO-34- DIHYDROPYRIMIDIN-1(2H)-YL)ETHOXY)PHENOXY)-4-METHYLNAPHTHALEN-1-YL)-N- METHYLACETAMIDE (JLJ686) A NON-NUCLEOSIDE INHIBITOR
97, d4id5A1, 0.9283, 2.44, 0.969, 429, 422, HIV-1 REVERSE TRANSCRIPTASE WITH BOUND FRAGMENT AT THE RNASE H PRIMER GRIP SITE
98, d5vqxA1, 0.9281, 2.30, 0.993, 422, 419, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (Y181C) VARIANT IN COMPLEX WITH 2-CHLORO-N-(6-CYANO-3-(2-(2-(24-DIOXO-34- DIHYDROPYRIMIDIN-1(2H)-YL)ETHOXY)PHENOXY)-4-METHYLNAPHTHALEN-1-YL)-N- METHYLACETAMIDE (JLJ686) A NON-NUCLEOSIDE INHIBITOR
99, d5vquA1, 0.9281, 2.30, 0.993, 424, 419, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (Y181C) VARIANT IN COMPLEX WITH N-(6-CYANO-3-(2-(2-(24-DIOXO-34-DIHYDROPYRIMIDIN- 1(2H)-YL)ETHOXY)PHENOXY)-4-METHYLNAPHTHALEN-1-YL)-2-FLUORO-N- METHYLACETAMIDE (JLJ683) A NON-NUCLEOSIDE INHIBITOR
100, d5vqvA1, 0.9277, 2.31, 0.993, 422, 419, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (Y181C) VARIANT IN COMPLEX WITH N-(6-CYANO-3-(2-(2-(24-DIOXO-34-DIHYDROPYRIMIDIN- 1(2H)-YL)ETHOXY)PHENOXY)-4-METHYLNAPHTHALEN-1-YL)-N-METHYLACRYLAMIDE (JLJ684) A NON-NUCLEOSIDE INHIBITOR
101, d2b5jA1, 0.9276, 2.40, 0.979, 429, 422, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH JANSSEN-R165481
102, d4rw8A1, 0.9275, 2.39, 0.972, 429, 422, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH (E)- 3-(3-CHLORO-5-(2-(2-(24-DIOXO-34-DIHYDROPYRIMIDIN-1(2H)-YL)ETHOXY) PHENOXY)PHENYL)ACRYLONITRILE (JLJ532) A NON-NUCLEOSIDE INHIBITOR 
103, d5cyqA1, 0.9273, 2.45, 0.972, 429, 422, HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH 4-BROMOPYRAZOLE
104, d3irxA1, 0.9273, 2.46, 0.986, 429, 422, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH THE NON-NUCLEOSIDE RT INHIBITOR (E)-S-METHYL 5-(1-(37-DIMETHYL-2-OXO-23-DIHYDROBENZO[D]OXAZOL-5-YL)-5- (5-METHYL-134-OXADIAZOL-2-YL)PENT-1-ENYL)-2-METHOXY-3- METHYLBENZOTHIOATE.
105, d5tuqA1, 0.9268, 2.52, 0.974, 429, 422, CRYSTAL STRUCTURE OF A 6-CYCLOHEXYLMETHYL-3-HYDROXYPYRIMIDINE-24- DIONE INHIBITOR IN COMPLEX WITH HIV REVERSE TRANSCRIPTASE
106, d4kfbA1, 0.9268, 2.45, 0.972, 429, 422, HIV-1 REVERSE TRANSCRIPTASE WITH BOUND FRAGMENT AT NNRTI ADJACENT SITE
107, d4i7gA1, 0.9268, 2.44, 0.972, 431, 422,  
108, d2yknA1, 0.9267, 2.44, 0.972, 431, 422, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH A DIFLUOROMETHYLBENZOXAZOLE (DFMB) PYRIMIDINE THIOETHER DERIVATIVE A NON-NUCLEOSIDE RT INHIBITOR (NNRTI)
109, d1lweA2, 0.9264, 2.22, 0.957, 429, 421, CRYSTAL STRUCTURE OF M41L/T215Y MUTANT HIV-1 REVERSE TRANSCRIPTASE (RTMN) IN COMPLEX WITH NEVIRAPINE
110, d5k14A1, 0.9263, 1.90, 0.959, 417, 414, HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH A 26-DIFLUOROPHENYL DAPY ANALOG
111, d5hbmA1, 0.9262, 2.12, 0.974, 422, 418, CRYSTAL STRUCTURE OF A DIHYDROXYCOUMARIN RNASE H ACTIVE-SITE INHIBITOR IN COMPLEX WITH HIV-1 REVERSE TRANSCRIPTASE
112, d2be2A1, 0.9262, 2.40, 0.972, 427, 422, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH R221239
113, d3m8qA1, 0.9261, 2.49, 0.974, 429, 422, HIV-1 RT WITH AMINOPYRIMIDINE NNRTI
114, d3qlhA1, 0.9259, 2.29, 0.979, 426, 422, HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH MANICOL AT THE RNASE H ACTIVE SITE AND TMC278 (RILPIVIRINE) AT THE NNRTI BINDING POCKET
115, d2vg7A1, 0.9258, 2.44, 0.976, 429, 421, CRYSTAL STRUCTURES OF HIV-1 REVERSE TRANSCRIPTASE COMPLEXES WITH THIOCARBAMATE NON-NUCLEOSIDE INHIBITORS
116, d3m8pA1, 0.9257, 2.16, 0.974, 423, 420, HIV-1 RT WITH NNRTI TMC-125
117, d3lp2A1, 0.9254, 2.27, 0.979, 425, 422, HIV-1 REVERSE TRANSCRIPTASE WITH INHIBITOR
118, d2vg6A1, 0.9253, 2.30, 0.972, 425, 422, CRYSTAL STRUCTURES OF HIV-1 REVERSE TRANSCRIPTASE COMPLEXES WITH THIOCARBAMATE NON-NUCLEOSIDE INHIBITORS
119, d1s1uA2, 0.9251, 2.17, 0.962, 427, 420, CRYSTAL STRUCTURE OF L100I MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH NEVIRAPINE
120, d4o44A1, 0.9250, 2.11, 0.978, 425, 418, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH 4- ((4-(MESITYLAMINO)-6-(3-MORPHOLINOPROPOXY)-135-TRIAZIN-2-YL)AMINO) BENZONITRILE (JLJ529) A NON-NUCLEOSIDE INHIBITOR
121, d1s1wA2, 0.9250, 2.40, 0.972, 429, 422, CRYSTAL STRUCTURE OF V106A MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH UC-781
122, d3nbpA1, 0.9247, 2.10, 0.981, 425, 418, HIV-1 REVERSE TRANSCRIPTASE WITH AMINOPYRIMIDINE INHIBITOR 2
123, d1bqnA2, 0.9246, 2.32, 0.979, 426, 422, TYR 188 LEU HIV-1 RT/HBY 097
124, d4g1qA1, 0.9245, 2.41, 0.972, 429, 422, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH RILPIVIRINE (TMC278 EDURANT) A NON-NUCLEOSIDE RT-INHIBITING DRUG
125, d2i5jA1, 0.9244, 2.41, 0.969, 429, 421, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH DHBNH AN RNASE H INHIBITOR
126, d4iclA1, 0.9243, 2.42, 0.974, 429, 422, HIV-1 REVERSE TRANSCRIPTASE WITH BOUND FRAGMENT AT THE INCOMING DNTP BINDING SITE
127, d4i2qA1, 0.9243, 2.41, 0.969, 429, 421, CRYSTAL STRUCTURE OF K103N/Y181C MUTANT OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH RILPIVIRINE (TMC278) ANALOGUE
128, d3tamA1, 0.9243, 2.51, 0.964, 429, 422, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (K103N MUTANT) IN COMPLEX WITH INHIBITOR M06
129, d2vg5A1, 0.9243, 2.26, 0.971, 423, 420, CRYSTAL STRUCTURES OF HIV-1 REVERSE TRANSCRIPTASE COMPLEXES WITH THIOCARBAMATE NON-NUCLEOSIDE INHIBITORS
130, d4lslA1, 0.9242, 2.19, 0.969, 423, 420, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH (E)- 3-(3-(4-CHLORO-2-(2-(24-DIOXO-34-DIHYDROPYRIMIDIN-1(2H)-YL)ETHOXY) PHENOXY)PHENYL)ACRYLONITRILE (JLJ476) A NON-NUCLEOSIDE INHIBITOR
131, d4i2pA1, 0.9242, 2.45, 0.972, 429, 422, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH RILPIVIRINE (TMC278) BASED ANALOGUE
132, d3medA1, 0.9241, 2.41, 0.974, 429, 421, HIV-1 K103N REVERSE TRANSCRIPTASE IN COMPLEX WITH TMC125
133, d2zd1A1, 0.9238, 2.28, 0.979, 429, 422, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH TMC278 (RILPIVIRINE) A NON-NUCLEOSIDE RT INHIBITOR
134, d3bgrA1, 0.9236, 2.40, 0.974, 429, 421, CRYSTAL STRUCTURE OF K103N/Y181C MUTANT HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH TMC278 (RILPIVIRINE) A NON-NUCLEOSIDE RT INHIBITOR
135, d2banA1, 0.9236, 2.45, 0.964, 429, 421, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH JANSSEN-R157208
136, d5tepA1, 0.9234, 2.42, 0.974, 429, 422, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH 7-(2- (2-(24-DIOXO-34-DIHYDROPYRIMIDIN-1(2H)-YL)ETHOXY)PHENOXY)-2- NAPHTHONITRILE (JLJ649) A NON-NUCLEOSIDE INHIBITOR
137, d5cymA1, 0.9233, 2.28, 0.969, 422, 418, HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH 4-IODOPYRAZOLE
138, d1uwbA2, 0.9231, 2.44, 0.969, 423, 420, TYR 181 CYS HIV-1 RT/8-CL TIBO
139, d1s9gA2, 0.9231, 2.41, 0.972, 429, 422, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH JANSSEN-R120394.
140, d1rt3A2, 0.9230, 2.51, 0.972, 429, 422, AZT DRUG RESISTANT HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH 1051U91
141, d1revA2, 0.9230, 2.02, 0.976, 423, 416, HIV-1 REVERSE TRANSCRIPTASE
142, d4o4gA1, 0.9229, 2.14, 0.978, 425, 418, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH 4- ((4-(MESITYLAMINO)-135-TRIAZIN-2-YL)AMINO)BENZONITRILE (JLJ527) A NON-NUCLEOSIDE INHIBITOR
143, d1bqmA2, 0.9227, 2.56, 0.969, 429, 422, HIV-1 RT/HBY 097
144, d1hpzA2, 0.9225, 2.45, 0.974, 429, 422, HUMAN IMMUNODEFICIENCY VIRUS TYPE 1
145, d5terA1, 0.9221, 2.48, 0.972, 429, 422, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH 5- CHLORO-7-(2-(2-(24-DIOXO-34-DIHYDROPYRIMIDIN-1(2H)-YL)ETHOXY) PHENOXY)-8-METHYL-2-NAPHTHONITRILE (JLJ651) A NON-NUCLEOSIDE INHIBITOR
146, d1s6qA2, 0.9220, 2.44, 0.993, 424, 419, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH JANSSEN-R147681
147, d4lsnA1, 0.9219, 2.43, 0.969, 429, 422, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH (E)- 3-(3-BROMO-5-(4-CHLORO-2-(2-(24-DIOXO-34-DIHYDROPYRIMIDIN-1(2H)- YL)ETHOXY)PHENOXY)PHENYL)ACRYLONITRILE (JLJ518) A NON-NUCLEOSIDE INHIBITOR
148, d4h4mA1, 0.9216, 2.55, 0.972, 429, 422, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH (E)- 3-(3-CHLORO-5-(4-CHLORO-2-(2-(24-DIOXO-34- DIHYDROPYRIMIDIN-1(2H)- YL)ETHOXY)PHENOXY)PHENYL)ACRYLONITRILE (JLJ494) A NON-NUCLEOSIDE INHIBITOR
149, d3mecA1, 0.9216, 2.49, 0.976, 429, 422, HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH TMC125
150, d5c24A1, 0.9215, 2.25, 0.981, 427, 420, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH 7- ((4-((4-CYANOPHENYL)AMINO)-135-TRIAZIN-2-YL)AMINO)-68- DIMETHYLINDOLIZINE-2-CARBONITRILE (JLJ605) A NON-NUCLEOSIDE INHIBITOR
151, d1tv6A2, 0.9215, 2.36, 0.978, 421, 417, HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH CP-94707
152, d5tw3A1, 0.9214, 2.31, 0.974, 425, 418, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH 5-(2- (2-(24-DIOXO-34-DIHYDROPYRIMIDIN-1(2H)-YL)ETHOXY)-4-FLUOROPHENOXY)- 7-FLUORO-2-NAPHTHONITRILE (JLJ636) A NON-NUCLEOSIDE INHIBITOR
153, d1hquA2, 0.9213, 2.32, 0.969, 425, 418, HUMAN IMMUNODEFICIENCY VIRUS TYPE 1
154, d4mfbA1, 0.9211, 2.50, 0.967, 429, 422, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH 8-(2- (2-(24-DIOXO-34-DIHYDROPYRIMIDIN-1(2H)-YL)ETHOXY)PHENOXY) INDOLIZINE-2-CARBONITRILE (JLJ555) A NON-NUCLEOSIDE INHIBITOR
155, d1dtqA2, 0.9204, 2.38, 0.971, 426, 419, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH PETT- 1 (PETT131A94)
156, d1vruA2, 0.9202, 2.19, 0.983, 425, 418, HIGH RESOLUTION STRUCTURES OF HIV-1 RT FROM FOUR RT- INHIBITOR COMPLEXES
157, d1fk9A2, 0.9199, 2.25, 0.981, 426, 419, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH DMP- 266(EFAVIRENZ)
158, d1tvrA2, 0.9195, 2.17, 0.981, 420, 417, HIV-1 RT/9-CL TIBO
159, d1s6pA2, 0.9179, 2.48, 0.979, 429, 422, CRYSTAL STRUCTURE OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH JANSSEN-R100943
160, d5vqsA1, 0.9178, 2.48, 0.972, 429, 422, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH N-(6- CYANO-3-(2-(2-(24-DIOXO-34-DIHYDROPYRIMIDIN-1(2H)-YL)ETHOXY) PHENOXY)-4-METHYLNAPHTHALEN-1-YL)ACRYLAMIDE (JLJ685) A NON- NUCLEOSIDE INHIBITOR
161, d1vrtA2, 0.9173, 2.60, 0.979, 426, 420, HIGH RESOLUTION STRUCTURES OF HIV-1 RT FROM FOUR RT- INHIBITOR COMPLEXES
162, d1s9eA2, 0.9170, 2.26, 0.983, 425, 418, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH JANSSEN-R129385
163, d2hndA1, 0.9159, 2.50, 0.974, 429, 422, CRYSTAL STRUCTURE OF K101E MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH NEVIRAPINE
164, d1sv5A2, 0.9154, 2.26, 0.978, 425, 418, CRYSTAL STRUCTURE OF K103N MUTANT HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH JANSSEN-R165335
165, d1suqA2, 0.9150, 2.69, 0.979, 429, 421, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH JANSSEN-R185545
166, d2opqA1, 0.9146, 2.53, 0.976, 429, 422, CRYSTAL STRUCTURE OF L100I MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GW420867X.
167, d2oppA2, 0.9125, 2.16, 0.981, 418, 415, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GW420867X.
168, d2hnyA1, 0.9113, 2.23, 0.983, 418, 415, CRYSTAL STRUCTURE OF E138K MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH NEVIRAPINE
169, d2hnzA1, 0.9097, 2.34, 0.978, 425, 418, CRYSTAL STRUCTURE OF E138K MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH PETT-2
170, d1eetA2, 0.9091, 2.19, 0.971, 419, 414, HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH THE INHIBITOR MSC204
171, d3qo9A1, 0.9090, 2.14, 0.976, 414, 411, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH TSAO-T A NON-NUCLEOSIDE RT INHIBITOR (NNRTI)
172, d4rw4A1, 0.9087, 2.69, 0.986, 429, 421, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (K103NY181C) VARIANT IN COMPLEX WITH (E)-3-(3-CHLORO-5-(4-CHLORO-2-(2-(24-DIOXO-34- DIHYDROPYRIMIDIN-1(2H)-YL)ETHOXY)PHENOXY)PHENYL)ACRYLONITRILE (JLJ494) A NON-NUCLEOSIDE INHIBITOR
173, d4rw9A1, 0.9086, 2.41, 0.990, 413, 412, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (Y181C) VARIANT IN COMPLEX WITH (E)-3-(3-CHLORO-5-(2-(2-(24-DIOXO-34-DIHYDROPYRIMIDIN- 1(2H)-YL)ETHOXY)PHENOXY)PHENYL)ACRYLONITRILE (JLJ532) A NON- NUCLEOSIDE INHIBITOR
174, d4rw7A1, 0.9080, 2.39, 0.993, 413, 412, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (K103N Y181C) VARIANT IN COMPLEX WITH (E)-3-(3-CHLORO-5-(2-(2-(24-DIOXO-34- DIHYDROPYRIMIDIN-1(2H)-YL)ETHOXY)PHENOXY)PHENYL)ACRYLONITRILE (JLJ532) A NON-NUCLEOSIDE INHIBITOR
175, d1lw2A2, 0.9080, 2.39, 0.990, 413, 412, CRYSTAL STRUCTURE OF T215Y MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH 1051U91
176, d3hvtA2, 0.9075, 2.35, 0.981, 419, 416, STRUCTURAL BASIS OF ASYMMETRY IN THE HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 REVERSE TRANSCRIPTASE HETERODIMER
177, d4rw6A1, 0.9072, 2.58, 0.902, 428, 419, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (Y181C) VARIANT IN COMPLEX WITH (E)-3-(3-CHLORO-5-(4-CHLORO-2-(2-(24-DIOXO-34- DIHYDROPYRIMIDIN-1(2H)-YL)ETHOXY)PHENOXY)PHENYL)ACRYLONITRILE (JLJ494) A NON-NUCLEOSIDE INHIBITOR
178, d2ic3A1, 0.9070, 2.42, 0.993, 413, 412, CRYSTAL STRUCTURE OF K103N/Y181C MUTANT HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH NONNUCLEOSIDE INHIBITOR HBY 097
179, d1tkzA2, 0.9069, 2.76, 0.972, 429, 422, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GW429576
180, d4puoC1, 0.9065, 2.15, 0.983, 414, 411, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH RNA/DNA AND NEVIRAPINE
181, d1tl1A2, 0.9064, 2.87, 0.969, 429, 422, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GW451211
182, d1tl3A2, 0.9060, 2.15, 0.983, 414, 411, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GW450557
183, d4we1A1, 0.9047, 2.16, 0.983, 414, 411, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH 5-(2- (2-(24-DIOXO-34-DIHYDROPYRIMIDIN-1(2H)-YL)ETHOXY)PHENOXY)-2- NAPHTHONITRILE (JLJ600)
184, d1tktA2, 0.9037, 2.75, 0.966, 423, 417, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GW426318
185, d4pwdC1, 0.9035, 2.16, 0.980, 413, 410, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH BULGE-RNA/DNA AND NEVIRAPINE
186, d1lw0A2, 0.9033, 2.89, 0.969, 429, 422, CRYSTAL STRUCTURE OF T215Y MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH NEVIRAPINE
187, d4puoA1, 0.9026, 2.26, 0.981, 415, 412, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH RNA/DNA AND NEVIRAPINE
188, d1ep4A2, 0.8998, 2.83, 0.964, 429, 422, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH S- 1153
189, d1lwcA2, 0.8994, 2.19, 0.993, 412, 410, CRYSTAL STRUCTURE OF M184V MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH NEVIRAPINE
190, d4pwdA1, 0.8981, 2.20, 0.976, 413, 410, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH BULGE-RNA/DNA AND NEVIRAPINE
191, d1t03A2, 0.8941, 2.91, 0.967, 429, 422, HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO TENOFOVIR TERMINATED TEMPLATE-PRIMER (COMPLEX P)
192, d1n5yA2, 0.8910, 2.80, 0.964, 429, 420, HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO POST- TRANSLOCATION AZTMP-TERMINATED DNA (COMPLEX P)
193, d2hmiA2, 0.8909, 2.86, 0.964, 429, 420, HIV-1 REVERSE TRANSCRIPTASE/FRAGMENT OF FAB 28/DNA COMPLEX
194, d1j5oA2, 0.8900, 2.86, 0.950, 429, 420, CRYSTAL STRUCTURE OF MET184ILE MUTANT OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH DOUBLE STRANDED DNA TEMPLATE- PRIMER
195, d1r0aA2, 0.8837, 2.82, 0.943, 429, 419, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE COVALENTLY TETHERED TO DNA TEMPLATE-PRIMER SOLVED TO 2.8 ANGSTROMS
196, d1hysA2, 0.8832, 2.95, 0.962, 429, 420, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH A POLYPURINE TRACT RNA:DNA
197, d1n6qA2, 0.8820, 3.01, 0.955, 429, 420, HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO PRE- TRANSLOCATION AZTMP-TERMINATED DNA (COMPLEX N)
198, d3kjvA1, 0.8568, 2.97, 0.962, 429, 420, HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH DNA
199, d1c0tA2, 0.8514, 3.14, 0.912, 422, 411, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH BM+21.1326
200, d1t05A2, 0.8479, 1.74, 0.976, 380, 378, HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO TEMPLATE-PRIMER WITH TENOFOVIR-DIPHOSPHATE BOUND AS THE INCOMING NUCLEOTIDE SUBSTRATE
201, d1rtdA2, 0.8463, 3.55, 0.928, 429, 418, STRUCTURE OF A CATALYTIC COMPLEX OF HIV-1 REVERSE TRANSCRIPTASE: IMPLICATIONS FOR NUCLEOSIDE ANALOG DRUG RESISTANCE
202, d3kk3A1, 0.8461, 3.60, 0.957, 429, 420, HIV-1 REVERSE TRANSCRIPTASE-DNA COMPLEX WITH GS-9148 TERMINATED PRIMER
203, d4pquA1, 0.8385, 3.54, 0.900, 429, 418, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH RNA/DNA AND DATP
204, d1rtdC2, 0.8353, 3.76, 0.938, 429, 420, STRUCTURE OF A CATALYTIC COMPLEX OF HIV-1 REVERSE TRANSCRIPTASE: IMPLICATIONS FOR NUCLEOSIDE ANALOG DRUG RESISTANCE
205, d4dg1A1, 0.8332, 3.78, 0.938, 429, 420, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) WITH POLYMORPHISM MUTATION K172A AND K173A
206, d3kk1A1, 0.8331, 3.33, 0.936, 429, 389, HIV-1 REVERSE TRANSCRIPTASE-DNA COMPLEX WITH NUCEOTIDE INHIBITOR GS- 9148-DIPHOSPHATE BOUND IN NUCLEOTIDE SITE
207, d4pquC1, 0.8319, 3.78, 0.947, 429, 418, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH RNA/DNA AND DATP
208, d3kk2A1, 0.8288, 3.83, 0.931, 429, 419, HIV-1 REVERSE TRANSCRIPTASE-DNA COMPLEX WITH DATP BOUND IN THE NUCLEOTIDE BINDING SITE
209, d3dlkA1, 0.8252, 3.88, 0.926, 429, 418, CRYSTAL STRUCTURE OF AN ENGINEERED FORM OF THE HIV-1 REVERSE TRANSCRIPTASE RT69A
210, d3ig1A1, 0.8188, 3.15, 0.943, 427, 383, HIV-1 REVERSE TRANSCRIPTASE WITH THE INHIBITOR BETA- THUJAPLICINOL BOUND AT THE RNASE H ACTIVE SITE
211, d1hvuJ2, 0.8100, 3.43, 0.935, 427, 386, HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 REVERSE TRANSCRIPTASE COMPLEXED WITH A 33-BASE NUCLEOTIDE RNA PSEUDOKNOT
212, d1hvuG2, 0.8100, 3.13, 0.963, 429, 375, HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 REVERSE TRANSCRIPTASE COMPLEXED WITH A 33-BASE NUCLEOTIDE RNA PSEUDOKNOT
213, d1hvuD2, 0.8100, 3.13, 0.963, 429, 375, HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 REVERSE TRANSCRIPTASE COMPLEXED WITH A 33-BASE NUCLEOTIDE RNA PSEUDOKNOT
214, d1hvuA2, 0.8100, 3.13, 0.963, 429, 375, HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 REVERSE TRANSCRIPTASE COMPLEXED WITH A 33-BASE NUCLEOTIDE RNA PSEUDOKNOT
215, d3kliA1, 0.7958, 3.13, 0.963, 429, 375, CRYSTAL STRUCTURE OF UNLIGANDED AZT-RESISTANT HIV-1 REVERSE TRANSCRIPTASE
216, d3ithC1, 0.7958, 3.16, 0.952, 429, 372, CRYSTAL STRUCTURE OF THE HIV-1 REVERSE TRANSCRIPTASE BOUND TO A 6-VINYLPYRIMIDINE INHIBITOR
217, d4zhrA1, 0.7954, 3.24, 0.952, 429, 376, STRUCTURE OF HIV-1 RT Q151M MUTANT
218, d3ithA1, 0.7899, 3.03, 0.925, 429, 373, CRYSTAL STRUCTURE OF THE HIV-1 REVERSE TRANSCRIPTASE BOUND TO A 6-VINYLPYRIMIDINE INHIBITOR
219, d2iajA1, 0.7890, 3.16, 0.957, 429, 373, CRYSTAL STRUCTURE OF K103N/Y181C MUTANT HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH ATP
220, d5j1eC1, 0.7848, 3.13, 0.957, 429, 370, CRYSTAL STRUCTURE OF A HYDROXYPYRIDONE CARBOXYLIC ACID ACTIVE-SITE RNASE H INHIBITOR IN COMPLEX WITH HIV REVERSE TRANSCRIPTASE
221, d1qe1A2, 0.7842, 3.19, 0.957, 423, 368, CRYSTAL STRUCTURE OF 3TC-RESISTANT M184I MUTANT OF HIV-1 REVERSE TRANSCRIPTASE
222, d3isnC1, 0.7836, 3.24, 0.943, 429, 370, CRYSTAL STRUCTURE OF HIV-1 RT BOUND TO A 6-VINYLPYRIMIDINE INHIBITOR
223, d5uv5C1, 0.7819, 3.43, 0.957, 429, 376, CRYSTAL STRUCTURE OF A 2-HYDROXYISOQUINOLINE-13-DIONE RNASE H ACTIVE SITE INHIBITOR WITH MULTIPLE BINDING MODES TO HIV REVERSE TRANSCRIPTASE
224, d4mh8A_, 0.7798, 2.92, 0.945, 421, 362, THE CRYSTAL STRUCTURE OF THE MONOMERIC REVERSE TRANSCRIPTASE FROM MOLONEY MURINE LEUKEMIA VIRUS
225, d1dloA2, 0.7778, 4.01, 0.185, 453, 394, HUMAN IMMUNODEFICIENCY VIRUS TYPE 1
226, d1hqeA2, 0.7769, 4.01, 0.185, 453, 394, HUMAN IMMUNODEFICIENCY VIRUS TYPE 1
227, d5j1eA1, 0.7745, 3.18, 0.973, 429, 368, CRYSTAL STRUCTURE OF A HYDROXYPYRIDONE CARBOXYLIC ACID ACTIVE-SITE RNASE H INHIBITOR IN COMPLEX WITH HIV REVERSE TRANSCRIPTASE
228, d1mu2A2, 0.7707, 3.30, 0.943, 429, 369, CRYSTAL STRUCTURE OF HIV-2 REVERSE TRANSCRIPTASE
229, d5uv5A1, 0.7690, 2.96, 0.961, 417, 361, CRYSTAL STRUCTURE OF A 2-HYDROXYISOQUINOLINE-13-DIONE RNASE H ACTIVE SITE INHIBITOR WITH MULTIPLE BINDING MODES TO HIV REVERSE TRANSCRIPTASE
230, d1hmvG2, 0.7680, 2.81, 0.582, 412, 352, THE STRUCTURE OF UNLIGANDED REVERSE TRANSCRIPTASE FROM THE HUMAN IMMUNODEFICIENCY VIRUS TYPE 1
231, d1hmvE2, 0.7680, 3.08, 0.947, 410, 357, THE STRUCTURE OF UNLIGANDED REVERSE TRANSCRIPTASE FROM THE HUMAN IMMUNODEFICIENCY VIRUS TYPE 1
232, d1hmvC2, 0.7680, 3.22, 0.961, 411, 361, THE STRUCTURE OF UNLIGANDED REVERSE TRANSCRIPTASE FROM THE HUMAN IMMUNODEFICIENCY VIRUS TYPE 1
233, d1hmvA2, 0.7680, 3.22, 0.961, 411, 361, THE STRUCTURE OF UNLIGANDED REVERSE TRANSCRIPTASE FROM THE HUMAN IMMUNODEFICIENCY VIRUS TYPE 1
234, p3klhA1, 0.5324, 3.22, 0.961, 411, 361, CRYSTAL STRUCTURE OF AZT-RESISTANT HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO POST-TRANSLOCATION AZTMP-TERMINATED DNA (COMPLEX P)
235, p4b3oA1, 0.5164, 3.22, 0.961, 411, 361, STRUCTURES OF HIV-1 RT AND RNA-DNA COMPLEX REVEAL A UNIQUE RT CONFORMATION AND SUBSTRATE INTERFACE
236, p5xn0C1, 0.5150, 1.59, 0.970, 242, 234, HIV-1 REVERSE TRANSCRIPTASE Q151M:DNA BINARY COMPLEX
237, p6bsgA1, 0.5143, 1.35, 0.996, 226, 224, STRUCTURE OF HIV-1 RT COMPLEXED WITH RNA/DNA HYBRID IN AN RNA HYDROLYSIS-OFF MODE
238, p4q0bC1, 0.5138, 1.55, 0.920, 234, 226, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GAP- RNA/DNA AND NEVIRAPINE
239, p4q0bA1, 0.5128, 1.39, 0.996, 225, 223, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GAP- RNA/DNA AND NEVIRAPINE
240, p6bshA1, 0.5126, 2.72, 0.979, 244, 236, STRUCTURE OF HIV-1 RT COMPLEXED WITH RNA/DNA HYBRID IN THE RNA HYDROLYSIS MODE
241, p5hlfC1, 0.5123, 2.78, 0.992, 244, 237, STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH A 38-MER HAIRPIN TEMPLATE-PRIMER DNA APTAMER AND AN ALPHA-CARBOXYPHOSPHONATE INHIBITOR
242, p3v81A1, 0.5112, 1.39, 0.995, 224, 222, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) WITH DNA AND THE NONNUCLEOSIDE INHIBITOR NEVIRAPINE
243, p6bsjA1, 0.5108, 2.10, 0.983, 237, 230, STRUCTURE OF HIV-1 RT COMPLEXED WITH AN RNA/DNA HYBRID SEQUENCE NON- PREFERRED FOR RNA HYDROLYSIS
244, p6bsiA1, 0.5108, 2.72, 0.979, 244, 236, STRUCTURE OF HIV-1 RT COMPLEXED WITH AN RNA/DNA HYBRID CONTAINING THE POLYPURINE-TRACT SEQUENCE
245, p5d3gA1, 0.5094, 1.31, 0.991, 223, 221, STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE BOUND TO A NOVEL 38-MER HAIRPIN TEMPLATE-PRIMER DNA APTAMER
246, p5d3gC1, 0.5090, 1.33, 0.995, 223, 221, STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE BOUND TO A NOVEL 38-MER HAIRPIN TEMPLATE-PRIMER DNA APTAMER
247, p5i42A1, 0.5089, 1.99, 0.956, 236, 228, STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH A DNA APTAMER AZTTP AND CA(2+) ION
248, p5i3uC1, 0.5066, 1.90, 0.956, 236, 227, STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE N-SITE COMPLEX; CATALYTIC INCORPORATION OF AZTMP TO A DNA APTAMER IN CRYSTAL
249, p5hroA1, 0.5065, 2.49, 0.979, 243, 235, STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH A DNA APTAMER AND AN ALPHA-CARBOXY NUCLEOSIDE PHOSPHONATE INHIBITOR (ALPHA-CNP)
250, p5hlfA1, 0.5052, 2.30, 0.983, 237, 230, STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH A 38-MER HAIRPIN TEMPLATE-PRIMER DNA APTAMER AND AN ALPHA-CARBOXYPHOSPHONATE INHIBITOR
251, p5hp1C1, 0.5024, 2.42, 0.970, 240, 233, STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH A DNA APTAMER AND FOSCARNET A PYROPHOSPHATE ANALOG
252, p5xn2C1, 0.5019, 2.22, 0.978, 236, 229, HIV-1 REVERSE TRANSCRIPTASE Q151M:DNA:DGTP TERNARY COMPLEX
253, p5c42A1, 0.5016, 2.21, 0.956, 237, 228, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (K101P) VARIANT IN COMPLEX WITH 8-(2-(2-(24-DIOXO-34-DIHYDROPYRIMIDIN-1(2H)-YL) ETHOXY)PHENOXY)INDOLIZINE-2-CARBONITRILE (JLJ555) A NON-NUCLEOSIDE INHIBITOR
254, p3v6dC1, 0.5012, 2.22, 0.952, 235, 228, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) CROSS-LINKED WITH AZT-TERMINATED DNA
255, p2womA1, 0.5010, 1.46, 0.986, 221, 218, CRYSTAL STRUCTURE OF UK-453061 BOUND TO HIV-1 REVERSE TRANSCRIPTASE (K103N).
256, d2r2sA_, 0.5008, 2.28, 0.978, 236, 228, CO(III)BLEOMYCINB2 BOUND TO D(ATTAGTTATAACTAAT) COMPLEXED WITH MMLV RT CATALYTIC FRAGMENT
257, p5vz6A1, 0.5003, 1.41, 0.995, 224, 218, HIV REVERSE TRANSCRIPTASE COMPLEXED WITH (E)-3-(PYRIMIDIN-2-YL)-N-(5- (5;6;7;8-TETRAHYDRONAPHTHALEN-2-YL)-1H-PYRAZOL-3-YL)ACRYLAMIDE 
